Marie Classon

Pfizer (United States) — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

31h-index8.5kcitations100works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Epigenetics and DNA Methylation(38), Histone Deacetylase Inhibitors Research(25), Lymphoma Diagnosis and Treatment(24), Chronic Lymphocytic Leukemia Research(23), Chronic Myeloid Leukemia Treatments(21)

Publications100 total

Author response: KDM5 demethylases suppress R-loop-mediated ‘viral mimicry’ and DNA damage in breast cancer cells
2025Open Access
KDM5 demethylases suppress R-loop-mediated ‘viral mimicry’ and DNA damage in breast cancer cells
eLife·2025Open Access
KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells
2025Open Access
Author response: KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells
2025Open Access
KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells
2025Open Access
KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells
2025Open Access
KDM5 demethylases suppress R-loop-mediated “viral mimicry” and DNA damage in breast cancer cells
2025Open Access
Retroelement decay by the exonuclease XRN1 is a viral mimicry dependency in cancer
Cell Reports·2024· 19 citedOpen Access
Proceedings of the inaugural Dark Genome Symposium: November 2022
Mobile DNA·2023· 4 citedOpen Access
Figure S1 from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
Figure S2 from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
Figure S4 from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
Figure S2 from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
Supplementary Tables from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
Figure S5 from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
Supplementary Information from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
Supplementary Information from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
Figure S5 from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
Data from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
Figure S3 from A KDM5 Inhibitor Increases Global H3K4 Trimethylation Occupancy and Enhances the Biological Efficacy of 5-Aza-2′-Deoxycytidine
2023Open Access
page 1 of 5Next →

Frequent Co-authors

David Arnott(8), Marie Arsenian‐Henriksson(8), Tommy K. Cheung(7), Patrick Trojer(7), János Sümegi(6), George Klein(6), Jeff Settleman(5), Jeffrey Settleman(5), Charles Tindell(5), Catherine Wilson(5), Gulfem D. Guler(5), Benjamin Haley(5), Ed Harlow(4), Nicholas J. Dyson(4), Jean-Philippe Stéphan(4), Sreenath V. Sharma(3), Diana Lee(3), Daniel A. Haber(3), Maia Vinogradova(3), Victor Gehling(3)